Majority of TP53 variants were in CMS2 subgroup. »
10/11/24

Hypofractionated radiotherapy for MCC associated with similar treatment outcomes. »
10/11/24

RAI group demonstrated higher percentage of excellent treatment responses. »
10/14/24

GC patients with higher Sp1 levels exhibited improved response to immunotherapy. »
10/14/24

CRM prognostic for patients with resectable PDAC. »
10/15/24

Patient and tumor characteristics equally distributed across IPAQ categories. »
10/16/24

Phenotype III tumors had decreased 5-year overall survival. »
10/17/24

Plasma IL-8 levels higher in EBC patients. »
10/16/24

Genes of hCAFs/KKU-M213 but not of KKU-M213 tumors increased tumor lesions. »
10/17/24

Survival and recurrence of dormant mammary tumor cells following therapy dependent upon autophagy. »
10/18/24